Evaluation of tumor targets selected from public genomic databases for imaging of pancreatic ductal adenocarcinoma

Evaluation of tumor targets selected from public genomic databases for imaging of pancreatic ductal adenocarcinoma

Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a 5-year survival rate of approximately 5–7%, and complete surgical resection remains the only curative treatment but is often unfeasible. Fluorescence-guided surgery (FGS) using tumor-targeted probes may improve tumor...

Full description

Saved in:
Bibliographic Details
Main Authors: Nada Badr, Luca Ten Elshof, Ruben D. Houvast, Lysanne D. A. N. de Muynck, A. Stijn L. P. Crobach, Gerard J. P. van Westen, Ronald L. P. van Vlierberghe, J. Sven D. Mieog, Alexander L. Vahrmeijer, Peter J. K. Kuppen
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Pancreatic cancer
Tumor-target selection
Fluorescence-guided surgery
Data-driven approach
Molecular imaging
Online Access:https://doi.org/10.1038/s41598-025-00517-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-00517-1

Similar Items